Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-21-003944
Filing Date
2021-04-05
Accepted
2021-04-05 17:34:27
Documents
1
Period of Report
2021-04-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 6911
  Complete submission text file 0001214659-21-003944.txt   8419
Mailing Address 4340 E KENTUCKY AVE SUITE 206 GLENDALE CO 80246
Business Address 4340 E KENTUCKY AVE SUITE 206 GLENDALE CO 80246 3034957583
NEXIEN BIOPHARMA, INC. (Issuer) CIK: 0001625288 (see all company filings)

EIN.: 262049376 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 101 WINGER DRIVE NEDERLAND CO 80466
Business Address
Wasoff Evan L (Reporting) CIK: 0001719738 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55320 | Film No.: 21806862